His primary scientific interests are in Cancer research, Angiogenesis, Internal medicine, Molecular biology and Immunology. His Cancer research study combines topics in areas such as Mutation, Carcinogenesis, Cancer and Vascular endothelial growth factor A. His biological study spans a wide range of topics, including Tumor progression, Biochemistry and Metronomic Chemotherapy.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Progeria, Oncology and Progerin. His study in Molecular biology is interdisciplinary in nature, drawing from both Enhancer, Transcription factor, Gene expression, Zebrafish and Regulation of gene expression. His Gene expression research includes themes of Myeloid, Myelopoiesis and Danio.
His primary areas of study are Internal medicine, Cancer research, Pathology, Glioma and Oncology. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology, Surgery and Cardiology. His Surgery study combines topics from a wide range of disciplines, such as Neurology and Pediatrics.
While the research belongs to areas of Cancer research, Mark W. Kieran spends his time largely on the problem of Cancer, intersecting his research to questions surrounding Pharmacology. His studies deal with areas such as Medulloblastoma, Progressive disease, Regimen and Neurofibromatosis as well as Oncology. His Disease research incorporates elements of Clinical trial and Progeria.
Cancer research, Internal medicine, Oncology, Glioma and Cancer are his primary areas of study. His specific area of interest is Cancer research, where he studies Low-Grade Glioma. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Dabrafenib.
His Oncology research focuses on subjects like Neurofibromatosis, which are linked to Astrocytoma. His work deals with themes such as Clinical trial, Pathology and Microglia, which intersect with Glioma. His Cancer research is multidisciplinary, incorporating elements of Angiogenesis, Macrophage, Gene and Family medicine.
His primary areas of investigation include Cancer research, Internal medicine, Clinical trial, Cohort and Proinflammatory cytokine. His primary area of study in Cancer research is in the field of Melanoma. The various areas that he examines in his Internal medicine study include Gastroenterology and Oncology.
His Clinical trial research integrates issues from Young adult, Medulloblastoma, Dabrafenib, Glioma and Confounding. Mark W. Kieran focuses mostly in the field of Cohort, narrowing it down to topics relating to Cohort study and, in certain cases, Hazard ratio, Cause of death and Mortality rate. Mark W. Kieran interconnects BRAF V600E and Pathology in the investigation of issues within Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product
Mark Kieran;Volker Blank;Frédérique Logeat;Joël Vandekerckhove.
Identification of fibroblast heterogeneity in the tumor microenvironment
Hikaru Sugimoto;Thomas M Mundel;Mark W. Kieran;Raghu Kalluri.
Cancer Biology & Therapy (2006)
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
Hikaru Sugimoto;Yuki Hamano;David Charytan;Dominic Cosgrove.
Journal of Biological Chemistry (2003)
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors
Joshua B. Rubin;Andrew L. Kung;Robyn S. Klein;Jennifer A. Chan.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Intraembryonic hematopoietic cell migration during vertebrate development
H W Detrich;M W Kieran;F Y Chan;L M Barone.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov.
Nature Genetics (2013)
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott.
Cancer Cell (2014)
Myelopoiesis in the zebrafish, Danio rerio
Carolyn M. Bennett;Carolyn M. Bennett;Carolyn M. Bennett;John P. Kanki;John P. Kanki;John P. Kanki;Jennifer Rhodes;Jennifer Rhodes;Jennifer Rhodes;Ting X. Liu;Ting X. Liu;Ting X. Liu.
The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis.
M. A. Thompson;D. G. Ransom;S. J. Pratt;H. Maclennan.
Developmental Biology (1998)
In Vivo Endothelial siRNA Delivery Using Polymeric Nanoparticles With Low Molecular Weight
James E. Dahlman;Carmen Barnes;Omar F. Khan;Aude Thiriot.
Nature Nanotechnology (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: